As a result, McKesson can now provide customers with the same distribution service for plasma and biologics products that they have come to rely upon for pharmaceuticals.
McKesson Plasma and BioLogics, a full service authorized distributor, will distribute plasma and biologics products directly from the manufacturer to customers across the continuum of care.
John Figueroa, president of McKesson US Pharmaceutical, said: “McKesson is committed to providing our customers with end-to-end solutions designed to help them capitalize on today’s opportunities, as well as address key challenges. The new McKesson Plasma and BioLogics business unit is the latest example of McKesson’s focus on delivering the integrated solutions that are empowering hospital pharmacies to achieve new levels of efficiency.”